Expression of Fas-Fas Ligand Antigens and Apoptotic Marker APO2.7 by the Human Conjunctival Epithelium. Positive Correlation with Class II HLA DR Expression in Inflammatory Ocular Surface Disorders

doi:10.1006/exer.1998.0566

Experimental Eye Research

Volume 67, Issue 6, December 1998, Pages 687-697

https://doi.org/10.1006/exer.1998.0566 Get rights and content

Abstract

Fas antigen (CD95) is a membrane receptor that plays a major role in induction of apoptosis. In surface conjunctival epithelial cells the expressions of Fas, Fas ligand, the apoptotic marker APO2.7 and of HLA DR class II antigen, a membrane marker known to be expressed in inflammatory conditions were investigated. Impression cytology specimens were collected in 65 patients: 20 normal ones, 15 contact lens wearers, 20 receiving chronic topical antiglaucoma treatment and 10 with nonspecific chronic conjunctivitis. Cells were processed for flow cytometry, using monoclonal antibodies to Fas, Fas ligand, APO2.7, HLA DR antigens and a negative isotypic control. Percentages of positive cells were recorded and levels of fluorescence quantified using fluorescent beads at standardized fluorescence intensities. In addition, a human conjunctival cell line was incubated with anti-Fas stimulating antibodies in order to test Fas-induced apoptosis in vitro. Fas was found in all specimens in most of the conjunctival cells, but quantitation of levels of fluorescence showed a significantly higher expression in pathologic eyes than in normal ones. Fas ligand and APO2.7 were variably expressed by conjunctival cells, but in a significantly higher percentage of cells in pathological eyes than in normal ones. In these eyes a strong expression of HLA DR was also observed, whereas normal eyes showed lowest levels. Highly significant correlations were found between Fas, Fas ligand, APO2.7 and HLA DR levels. Anti-Fas antibodies in vitro induced strong apoptosis in epithelial cells as confirmed by APO2.7 expression and DAPI staining. This study confirms that conjunctival epithelial cells normally express Fas antigen, and more inconstantly its ligand, as do corneal ones or keratinocytes. Fluorescence quantitation by flow cytometry showed much higher expression in inflammatory eyes than in normal ones, and demonstrated a strong correlation between apoptotic and inflammatory pathways in the ocular surface.

References (32)

C. Baudouin et al.
Expression of inflammatory membrane markers by conjunctival cells in chronically treated glaucoma patients
Ophthalmology
(1994)
P. Esser et al.
CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells
Biochem. Biophys. Res. Commun.
(1995)
T.S. Griffith et al.
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
Immunity
(1996)
R.R. Mohan et al.
Apoptosis in the cornea: further characterization of Fas/Fas ligand system
Exp. Eye Res.
(1997)
N. Nonomura et al.
Fas/APO-1-mediated apoptosis of human renal cell carcinoma
Biochem. Biophys. Res. Commun.
(1996)
K. Sayama et al.
Expression of Fas antigen on keratinocytes in vivo and induction for apoptosis in cultured keratinocytes
J. Invest. Dermatol.
(1994)
T. Suda et al.
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
Cell
(1993)
H. Takahashi et al.
Interferon-gamma-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C
J. Invest. Dermatol.
(1995)
A.N. Theofilopoulos
The basis of autoimmunity: Part I. Mechanisms of aberrant self recognition
Immunol Today
(1995)
J.P. Truman et al.
HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes
Blood
(1997)

C. Baudouin et al.

Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation

Invest. Ophthalmol. Vis. Sci.

(1997)

C. Baudouin et al.

Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens

Br. J. Ophthalmol.

(1992)

M.M. Brysk et al.

Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes

J. Interferon Cytokine Res.

(1995)

L.E. French et al.

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

J. Cell Biol.

(1996)

A. Gessl et al.

Influence of tumour necrosis factor-alpha on the expression of Fc IgG and IgA receptors, and other markers by cultured human blood monocytes and U937 cells

Sand. J. Immunol.

(1994)

T.S. Griffith et al.

Fas ligand-induced apoptosis as a mechanism of immune privilege

Science

(1995)

Cited by (86)

Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options
2022, Progress in Retinal and Eye Research
Citation Excerpt :
The expression of these checkpoints in CoM is unknown, but may be relevant in cases that fail to respond against immunotherapy. Even so, Fas Ligand is a suppressor of immune activity and being expressed in conjunctival epithelium (Brignole et al., 1998), may contribute to CoM resistance against new therapies. Despite a limited number of studies on CoM, several conclusions can be drawn regarding the role of the immune infiltrate (Table 6).
Recent developments in oncology have led to a better molecular and cellular understanding of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare but potentially devastating disease. A better understanding of CoM, leading to the development of novel therapies, is urgently needed.
CoM is characterized by mutations that have also been identified in cutaneous melanoma, e.g. in BRAF, NRAS and TERT. These mutations are distinct from the mutations found in uveal melanoma (UM), affecting genes such as GNAQ, GNA11, and BAP1. Targeted therapies that are successful in cutaneous melanoma may therefore be useful in CoM.
A recent breakthrough in the treatment of patients with metastatic cutaneous melanoma was the development of immunotherapy. While immunotherapy is currently sparsely effective in intraocular tumours such as UM, the similarities between CoM and cutaneous melanoma (including in their immunological tumour micro environment) provide hope for the application of immunotherapy in CoM, and preliminary clinical data are indeed emerging to support this use.
This review aims to provide a comprehensive overview of the current knowledge regarding CoM, with a focus on the genetic and immunologic understanding. We elaborate on the distinct position of CoM in contrast to other types of melanoma, and explain how new insights in the pathophysiology of this disease guide the development of new, personalized, treatments.
Effect of Flos Buddlejae Granules on Apoptosis Factors Bax, Bcl-2, Fas and FasL in Lacrimal Gland Cells of Castrated Male Rabbits
2018, Digital Chinese Medicine
Objective To observe the effect of different concentration Flos Buddlejae (Mi Meng Hua, 密蒙花) granules on apoptosis factors of lacrimal gland cells of castrated male rabbits, and study the treatment effects of Flos Buddlejae (Mi Meng Hua, 密蒙花) granules in the dry eye model of castrated male rabbits.
Methods Flos Buddlejae (Mi Meng Hua, 密蒙花) raw material was made into granules. Thirty healthy adult New Zealand rabbits were randomly divided into five groups, six rabbits in each group. Group A: blank group, Group B: model group, Group C: Flos Buddlejae (Mi Meng Hua, 密蒙花) granule group, Group D: placebo group, Group E: testosterone group. Except for group A, all rabbits underwent removal of bilateral testis and epididymis. Rabbits in group C were administered Flos Buddlejae (Mi Meng Hua, 密蒙花) granules (100 mg/kg), three times per day; rabbits in group D were administered normal saline, three times per day. Rabbits in group E were injected with testosterone propionate (0.5 mL/kg) in the thigh muscle, every 3 days. All rabbits were tested by Schirmer I test (SIT) and tear film break-up time (BUT) before operation and 4 weeks after operation. After 4 weeks, all rabbits were sacrificed by air embolism and clipping of the lacrimal gland. Apoptosis factors, including Bax, Bcl-2, Fas and FasL of lacrimal gland cells were characterized by immunohistochemistry, and resulting data were statistically analyzed.
Results (1) Comparison of SIT and BUT before and after operation: There were statistically significant differences between groups B and D (P<0.01), but not among other groups (P>0.05). (2) Comparison of apoptosis factors Bax, Bcl-2 Fas and FasL: In a comparison of groups B and D, there was no statistically significant difference after operation (P>0.05). In a comparison of the other groups, there were statistically significant differences (P<0.01). In comparisons among A, C and E groups, there were no statistically significant differences (P>0.05).
Conclusion Compared with androgen, Flos Buddlejae (Mi Meng Hua, 密蒙花) granules caused similar but slightly weaker depression of Bax, Fas and FasL, and increased expression of Bcl-2.
HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease
2013, Experimental Eye Research
Citation Excerpt :
Since its introduction (Egbert et al., 1977), IC has been found to be useful in assessing the ocular surface in various ocular disorders such as dry eye/keratoconjunctivitis sicca (KCS; Wittpenn et al., 1986; Brignole et al., 2001), cicatricial ocular pemphigoid (Rivas et al., 2004), and vitamin A deficiency (McKelvie, 2003; Natadisastra et al., 1988) and has been used in clinical trials to evaluate HLA-DR expression in ocular surface diseases (Barabino et al., 2010; Mrugacz et al., 2007; Rolando et al., 2005; Baudouin et al., 2002; Brignole et al., 2000; Pisella et al., 2000; Tsubota et al., 1999; Baudouin et al., 1992, 1997). However, the reliability, reproducibility and storage limitations for the use of relative HLA-DR expression on IC-collected cells as a biomarker of inflammation for clinical trials has not yet been clearly established although there are several articles highlighting the uses of IC (Barabino et al., 2010; Baudouin et al., 1992, 1997, 2000; Brignole et al., 1998; Brignole et al., 2000; Brignole et al., 2001; Brignole-Baudouin et al., 2004a, 2004b; Calonge et al., 2004; Lopin et al., 2009; Fernandez et al., 2001; McKelvie, 2003; Natadisastra et al., 1987, 1988; Nelson et al., 1983; Puangsricharern and Tseng, 1995; Rolando et al., 2005; Roy et al., 2011; Singh et al., 2005; Stern et al., 2002; Stevenson et al., 2000; Thiel et al., 1997; Tole et al., 2001; Tseng, 1985. Tsubota et al., 1999; Wittpenn et al., 1986).
There are currently no validated minimally invasive objective metrics for the classification and evaluation of ocular surface diseases and/or for evaluating treatment efficacy. We thus sought to establish a standardized methodology for determining the relative amount of the inflammatory biomarker HLA-DR on the ocular surface and to evaluate the precision, reliability and repeatability of its use for large multicenter clinical trials and translational research studies of ocular surface disease. Multiple studies were conducted to establish a Standard Operating Procedure (SOP) for utilizing HLA-DR expression as a minimally invasive, objective, ocular surface inflammatory biomarker. The established SOPs provide specific guidelines for HLA-DR collection and analysis, in order to incorporate it reliably into multicenter clinical trials and/or translational research. Duplicate cell samples from impression cytology (IC) samples of both normal and dry eye individuals were collected and split to assess repeatability (between the splits and between the duplicate samples). To determine storage capability, one duplicate was stained immediately and the other after 30 days cold storage. To demonstrate the feasibility of the use of the SOP for a multicenter clinical trial, clinicians out-of-state were trained to collect IC samples, and the samples shipped to our Biomarker Laboratory, logged, processed and analyzed. Demonstration of the ability to incorporate of IC into a randomized double masked clinical trial of dry eye disease (DED) was performed. In all cases, processing and analyses were performed by a masked independent observer. The validity/viability of the SOPs was established by demonstrating that: 1) sufficient numbers of cells can be collected via IC; 2) the precision/repeatability of the relative biomarker expression quantified in samples; 3) personnel at distant sites can be taught to collect, store and ship samples successfully; 4) samples can be stored for up to 30 days (refrigeration) before processing without affecting results; 5) IC can be incorporated into a double blind randomized clinical trial (RCT) of DED; and 6) the Biomarker Laboratory can track a large number of masked samples reliably. In conclusion, our standard operating procedure for impression cytology analysis of HLA-DR expression appears to be repeatable and reproducible for use in multicenter clinical trials, providing a minimally invasive objective biomarker of inflammation of the ocular surface.
CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation
2012, Mucosal Immunology
Inappropriate expression of the chemokine CX3CL1 is reportedly known to act on inflammatory conditions in extraocular immune diseases. We studied the expression and effects of CX3CL1 in human patients, cultured human conjunctival cells, and transgenic mice exposed to benzalkonium chloride (BAC), a commonly used preservative in ophthalmic medications despite its proinflammatory properties, to determine whether CX3CL1 is involved in conjunctival inflammation. We report that CX3CL1 expression is increased in the conjunctiva of patients receiving BAC-containing medication, and correlates with clinical inflammation. BAC enhances the production of CX3CL1 in a conjunctival epithelial cell line, through the tumor-necrosis factor-α pathway, which attracts specific leukocyte subsets. In vivo, BAC-induced macrophage infiltration and subsequent inflammation of the conjunctiva is decreased in CX3CR1-deficient mice as compared with CX3CR1^+/+ controls. This translational study opens new avenue to investigate ocular surface disorders by focusing on chemokine-related inflammation and immune cell trafficking in the ocular conjunctival mucosa.
Topographical distribution and characterization of epithelial cells and intraepithelial lymphocytes in the human ocular mucosa
2012, Mucosal Immunology
The conjunctiva plays a key role in the protection of the ocular surface by initiating and regulating immune responses. In this study, we analyze the relative proportion of intraepithelial lymphocytes (IELs), apoptotic cells, and proliferative state in three different topographical regions of the normal human conjunctiva. Superior tarsal, superior bulbar, and inferior tarsal–bulbar–fornical conjunctival cells were collected by brush cytology from 63 healthy donors. Flow cytometry analysis showed higher levels of CD3⁺ and CD8⁺ IELs in both upper tarsal and bulbar conjunctiva than in the inferior tarsal–bulbar–fornix, where the CD19⁺ B cells were increased. For all zones two different cell populations (by cell size and complexity) were present in the apoptosis assay. The more complex cells were reduced within the inferior tarsal–bulbar–fornix when compared with the superior bulbar and tarsal areas. Less complex cells were more predominant in the inferior conjunctiva and were mainly alive. The mean proliferation index of the conjunctival epithelium was significantly lower in the superior bulbar conjunctiva than in superior tarsal and inferior fornical conjunctivas. These findings suggest that each topographical zone from normal human conjunctiva has a unique profile of immunophenotype, viability, and proliferative state that could be related to a differentiated regional functionality.
Immune response in the conjunctival epithelium of patients with dry eye
2010, Experimental Eye Research
The aim of our project was to test the hypothesis that patients with dry eye have a significant degree of inflammation and lymphocyte infiltration in conjunctival epithelium by using flow cytometry analysis of cells stored in cell culture medium. Impression cytology specimens were collected in 15 normal subjects and 15 dry eye patients. Samples collected from the right eye were placed in Phosphate Buffered Saline containing 0.05% paraformaldehyde (PFA), and samples from the left eye in cell culture medium containing 10% foetal calf serum (FCS). Phenotypic analysis was performed on cells derived from 21 dry eye patients and 16 healthy controls. The cells collected in FCS were stained for the expression of CK19, CD3, CD4, CD8, CD56, CD19, CD20, CD14 and HLA-DR, and analyzed by flow cytometry.
FCS samples contained a statistically increased number of cells when compared to PFA samples. No statistically significant differences were present in the number of CD45 + CK19- cells, CD3+ and CD4 + T cells, B and NK cells in dry eye patients compared to healthy controls. In the dry eye group there was a significant difference in the CD4/CD8 ratio respect to what observed in normal subjects, and an increased number of CD14+ cells. HLA-DR expression was increased only in CK19+ conjunctival epithelial cells of dry eye patients.
This study indicates that immune cells isolated from the superficial layer of the conjunctiva may play a pivotal role in the pathogenesis of dry eye, and that a new method of preservation of impression cytology samples can enhance flow cytometry analysis of epithelial and immune cells of the conjunctiva.

View all citing articles on Scopus

^f1: Correspondence to: C. Baudouin MD, PhD, Ambroise Paré Hospital, APHP, Department of Ophthalmology, 9 avenue Charles de Gaulle, 92104 Boulogne Cedex, France.

View full text

Regular articleExpression of Fas-Fas Ligand Antigens and Apoptotic Marker APO2.7 by the Human Conjunctival Epithelium. Positive Correlation with Class II HLA DR Expression in Inflammatory Ocular Surface Disorders

Abstract

Ophthalmology

Biochem. Biophys. Res. Commun.

Immunity

Exp. Eye Res.